457 related articles for article (PubMed ID: 36782251)
21. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
22. [Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway].
Wang L; Li F; Gu NN; Shen H; Han CL; Li KY; Yan RY; Wang J; Mi ZK
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):517-524. PubMed ID: 36725241
[TBL] [Abstract][Full Text] [Related]
23. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
24. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway.
Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J
J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948
[TBL] [Abstract][Full Text] [Related]
25. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
26. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
[TBL] [Abstract][Full Text] [Related]
27. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.
Zhao H; Ming T; Tang S; Ren S; Yang H; Liu M; Tao Q; Xu H
Mol Cancer; 2022 Jul; 21(1):144. PubMed ID: 35836256
[TBL] [Abstract][Full Text] [Related]
28. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
29. β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition.
Song Q; Han Z; Wu X; Wang Y; Zhou L; Yang L; Liu N; Sui H; Cai J; Ji Q; Li Q
Front Cell Dev Biol; 2021; 9():650067. PubMed ID: 33996812
[TBL] [Abstract][Full Text] [Related]
30. NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
Shi Y; Ge C; Fang D; Wei W; Li L; Wei Q; Yu H
Cancer Cell Int; 2022 Mar; 22(1):119. PubMed ID: 35292013
[TBL] [Abstract][Full Text] [Related]
31.
Jin Y; Chen W; Yang H; Yan Z; Lai Z; Feng J; Peng J; Lin J
Exp Ther Med; 2017 Dec; 14(6):5527-5534. PubMed ID: 29285087
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways.
Wan ML; Wang Y; Zeng Z; Deng B; Zhu BS; Cao T; Li YK; Xiao J; Han Q; Wu Q
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32149326
[TBL] [Abstract][Full Text] [Related]
33. Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine.
Ding MR; Qu YJ; Hu B; An HM
Biomed Pharmacother; 2022 Aug; 152():113208. PubMed ID: 35660246
[TBL] [Abstract][Full Text] [Related]
34. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
[TBL] [Abstract][Full Text] [Related]
35. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
[TBL] [Abstract][Full Text] [Related]
36. MRGBP promotes colorectal cancer metastasis via DKK1/Wnt/β-catenin and NF-kB/p65 pathways mediated EMT.
Long X; Hu Y; Duan S; Liu X; Huang W; Liu X; Xu Q; Song W; Zhou J
Exp Cell Res; 2022 Dec; 421(1):113375. PubMed ID: 36208716
[TBL] [Abstract][Full Text] [Related]
37. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
38. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
39. Thymol Isolated from
Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
[TBL] [Abstract][Full Text] [Related]
40. Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer
Li J; Zhou F; Shang L; Liu N; Liu Y; Zhang M; Wang S; Yang S
Front Oncol; 2022; 12():961653. PubMed ID: 36457504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
